Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Purchase individual online access for 1 year to this journal.
Price: EUR 595.00Impact Factor 2024: 3.4
The Journal of Alzheimer’s Disease is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer’s disease.
The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer’s disease.
Authors: Khalsa, Dharma Singh
Article Type: Review Article
Abstract: Although meditation is believed to be over five thousand years old, scientific research on it is in its infancy. Mitigating the extensive negative biochemical effects of stress is a superficially discussed target of Alzheimer’s disease (AD) prevention, yet may be critically important. This paper reviews lifestyle and stress as possible factors contributing to AD and meditation’s effects on cognition and well-being for reduction of neurodegeneration and prevention of AD. This review highlights Kirtan Kriya (KK), an easy, cost effective meditation technique requiring only 12 minutes a day, which has been successfully employed to improve memory in studies of people with …subjective cognitive decline, mild cognitive impairment, and highly stressed caregivers, all of whom are at increased risk for subsequent development of AD. KK has also been shown to improve sleep, decrease depression, reduce anxiety, down regulate inflammatory genes, upregulate immune system genes, improve insulin and glucose regulatory genes, and increase telomerase by 43%; the largest ever recorded. KK also improves psycho-spiritual well-being or spiritual fitness, important for maintenance of cognitive function and prevention of AD. KK is easy to learn and practice by aging individuals. It is the premise of this review that meditation in general, and KK specifically, along with other modalities such as dietary modification, physical exercise, mental stimulation, and socialization, may be beneficial as part of an AD prevention program. Show more
Keywords: Alzheimer’s disease, lifestyle, meditation, memory loss improvement, prevention, stress, psychospiritual well-being, reduction of risk factors
DOI: 10.3233/JAD-142766
Citation: Journal of Alzheimer's Disease, vol. 48, no. 1, pp. 1-12, 2015
Authors: Ashford, J. Wesson | Mahoney, Louise | Burkett, Tim
Article Type: Research Article
Abstract: Complementary and Integrative Medicine has been maturing as a field to support treatment for a variety of medical conditions. The approaches, including yoga, meditation, acupuncture, and dietary supplements, may assist patients in a variety of ways, though clear explanations for their mechanisms of action or measurements of their possible benefit are in most cases elusive. In this issue of the Journal of Alzheimer’s Disease, Khalsa examines the use of meditation as a stress-reduction technique and provides an argument that with a specific technique such stress reduction can be provided efficiently, with relatively little interference in daily activities, and might decrease …Alzheimer risk. This thorough review provides some evidence of physiological benefit of meditation to brain function. While any actual effect of meditation on Alzheimer pathophysiology is only conjectural, meditation has received considerable attention as a tool that may have positive psychological and medical benefits. Consequently, this review is welcome. What is less certain is whether the recommended meditation approach is of specific benefit for Alzheimer’s disease or any other condition above and beyond what might be provided by many other types of exercises (like singing in a chorus or doing cross-word puzzles) or physical activities (like swimming or yoga). Show more
Keywords: Meditation, Alzheimer’s disease, stress, psychological complementary medicine
DOI: 10.3233/JAD-150505
Citation: Journal of Alzheimer's Disease, vol. 48, no. 1, pp. 13-14, 2015
Authors: Siarkos, Kostas T. | Katirtzoglou, Everina A. | Politis, Antonios M.
Article Type: Review Article
Abstract: Depression in Alzheimer’s disease (dAD) is one of the most common behavioral and psychological symptoms of dementia, with devastating consequences not only for the affected individuals, but for caregivers as well. So far, pharmacological treatment of dAD has been based on the “monoamine hypothesis”. However, the reported moderate effects of approved antidepressants, as well as an increasing body of research evidence, suggest a more complex pathophysiologic mechanism. In the present paper, a systematic review of different treatments for dAD is presented that can inform the study of alternative neuropathological and neurobiological aspects of the disease aimed at the development of …more effective treatment targets. Show more
Keywords: Alzheimer’s disease, antidepressants, dementia, depression, treatment
DOI: 10.3233/JAD-148010
Citation: Journal of Alzheimer's Disease, vol. 48, no. 1, pp. 15-34, 2015
Authors: Shatenstein, Bryna | Barberger-Gateau, Pascale
Article Type: Research Article
Abstract: Brain aging is characterized by the progressive and gradual accumulation of detrimental changes in structure and function, which increase risk of age-related cognitive decline and dementia. This devastating chronic condition generates a huge social and economic burden and accounts for 11.2% of years of disability. The increase in lifespan has contributed to the increase in dementia prevalence; however, there is currently no curative treatment for most causes of dementias. This paper reviews evidence-based strategies to build, enhance, and preserve cognition over the lifespan by examining approaches that work best, proposing when in the life course they should be implemented, and …in which population group(s). Recent work shows a tendency to decreased age-specific prevalence and incidence of cognitive problems and dementia among people born later in the first half of the 20th century, citing higher educational levels, improvements in lifestyle, and better handling of vascular risk factors. This implies that we can target modifiable environmental, lifestyle, and health risk factors to modify the trajectory of cognitive decline before the onset of irreversible dementia. Because building cognitive reserve and prevention of cognitive decline are of critical importance, interventions are needed at every stage of the life course to foster cognitive stimulation, and enable healthy eating habits and physical activity throughout the lifespan. Preventive interventions to decrease and delay cognitive decline and its consequences in old age will also require collaboration and action on the part of policy-makers at the political and social level. Show more
Keywords: Alzheimer’s disease, cognition, cognitive reserve, dementia, early intervention, education, life course, lifestyle, prevention, psychosocial factors, social policies
DOI: 10.3233/JAD-150256
Citation: Journal of Alzheimer's Disease, vol. 48, no. 1, pp. 35-53, 2015
Authors: Liu, Jia | Zhu, Ming-wei | Arzberger, Thomas | Wang, Lu-ning
Article Type: Short Communication
Abstract: A clinicopathological investigation was conducted on a case of an 89-year-old man with a 10-year history of progressive dementia who also suffered strokes, apathy, aphasia, dysarthria, weakness of both legs, and walking difficulties. At autopsy, we found an obvious atrophy of the frontal and temporal cortex. Lewy bodies (LBs) could be seen in brain stem, amygdala, and neocortex. Argyrophilic grains were observed in hippocampus, entorhinal cortex, neocortex, amygdala, and pons, as well as neurofibrillary tangles in the entorhinal cortex and hippocampus. The case presented here is a rare case of frontotemporal lobar degeneration with accumulation of argyrophilic grains and Lewy …bodies. Show more
Keywords: Argyrophilic grains, frontotemporal lobar degeneration, FTLD-tau, Lewy bodies
DOI: 10.3233/JAD-150225
Citation: Journal of Alzheimer's Disease, vol. 48, no. 1, pp. 55-58, 2015
Authors: Fins, Joseph J.
Article Type: Editorial
Abstract: Using critical methods drawn from clinical ethics and the humanities, the author considers the posthumously published The Reagan Diaries and suggests that they show evidence of an incipient dementia. In the wake of Berisha et al.’s analysis of presidential press conferences during the Reagan presidency, published in the Journal of Alzheimer’s Disease , that were suggestive of cognitive impairment, this reading of the president’s diaries merit additional scrutiny. Diary entries from Reagan’s second term differ from the first years of his presidency. They demonstrate less text, more laconic analysis, word finding difficulties, evidence of spatial confusion and suggestions of …disinhibition, all possibly early signs of cognitive impoverishment during the same period when the transcripts of his second term press conferences showed evidence suggestive of incipient Alzheimer’s Disease. While a definitive analysis of the president’s diaries can not be performed on the abridged published text, edited by the historian Douglas Brinkley, these findings are suggestive and warrant additional scrutiny. By melding quantitative approaches analyzing language use from Reagan’s presidential press conferences with methods from clinical ethics and literary criticism, future scholars can gain a fuller understanding of the president’s health while he was in office. Show more
DOI: 10.3233/JAD-150354
Citation: Journal of Alzheimer's Disease, vol. 48, no. 1, pp. 59-61, 2015
Authors: Söllvander, Sofia | Ekholm-Pettersson, Frida | Brundin, Rose-Marie | Westman, Gabriel | Kilander, Lena | Paulie, Staffan | Lannfelt, Lars | Sehlin, Dag
Article Type: Research Article
Abstract: The Alzheimer’s disease (AD)-related peptide amyloid-β (Aβ) has a propensity to aggregate into various assemblies including toxic soluble Aβ protofibrils. Several studies have reported the existence of anti-Aβ antibodies in humans. However, it is still debated whether levels of anti-Aβ antibodies are altered in AD patients compared to healthy individuals. Formation of immune complexes with plasma Aβ makes it difficult to reliably measure the concentration of circulating anti-Aβ antibodies with certain immunoassays, potentially leading to an underestimation. Here we have investigated anti-Aβ antibody production on a cellular level by measuring the amount of anti-Aβ antibody producing cells instead of the …plasma level of anti-Aβ antibodies. To our knowledge, this is the first time the anti-Aβ antibody response in plasma has been compared in AD patients and age-matched healthy individuals using the enzyme-linked immunospot (ELISpot) technique. Both AD patients and healthy individuals had low levels of B cells producing antibodies binding Aβ40 monomers, whereas the number of cells producing antibodies toward Aβ42 protofibrils was higher overall and significantly higher in AD compared to healthy controls. This study shows, by an alternative and reliable method, that there is a specific immune response to the toxic Aβ protofibrils, which is significantly increased in AD patients. Show more
Keywords: Amyloid-β, amyloid-β protofibrils, anti-amyloid-β antibodies, enzyme-linked immunospot assay
DOI: 10.3233/JAD-150236
Citation: Journal of Alzheimer's Disease, vol. 48, no. 1, pp. 63-72, 2015
Authors: Snir, Jonatan A. | Suchy, Mojmir | Lawrence, Keith St. | Hudson, Robert H.E. | Pasternak, Stephen H. | Bartha, Robert
Article Type: Research Article
Abstract: Background: Cathepsin D (CatD) is a lysosomal protease that is elevated early in Alzheimer’s disease (AD). We have previously developed a Targeted contrast agent (CA) to detect CatD activity in vivo , consisting of a magnetic resonance imaging/fluorescent moiety linked to a cell penetrating peptide (CPP) by means of a CatD cleavage site and have demonstrated its uptake in the brain of an AD mouse model. Objective: The purpose of this study was to characterize the in vivo retention of a near infra-red fluorescent dye labeled version of this CA. Methods: …Six adult C57Bl/6 wild-type mice and six adult 5XFAD transgenic AD mice were studied using a small animal imaging system at five and twelve months of age using our novel Targeted CA, or two different control CAs; a Non-Targeted (lacking the CatD cleavage site) and a Non-Penetrating (lacking the CPP). Following intravenous CA administration, the optical signal was recorded within the brain and uptake and washout curves were measured and fitted to a one-phase exponential decay curve. Results: In all wild-type and 5XFAD mice, the washout of the Targeted CA that included a CPP domain was significantly slower than the washout of the Non-Penetrating and Non-Targeted CA. Furthermore, the washout of the CatD Targeted CA was significantly slower in the 5XFAD mice compared to the age matched wild-type controls (p < 0.05) at 5 and 12 months of age. Control CAs showed no differences in washout. Conclusions: The prolonged retention of the CatD targeted CA in 5XFAD mice suggests this agent may be useful for AD detection. Show more
Keywords: Alzheimer’s disease, Cathepsin D, molecular imaging, optical imaging, transgenic mice
DOI: 10.3233/JAD-150123
Citation: Journal of Alzheimer's Disease, vol. 48, no. 1, pp. 73-87, 2015
Authors: Zhang, Xiao-Fang | Zhao, Yan-Feng | Zhu, Shun-Wei | Huang, Wei-Jie | Luo, Yan | Chen, Qing-Ying | Ge, Li-Jun | Li, Run-Sheng | Wang, Jian-Fei | Sun, Mu | Xiao, Zhi-Cheng | Fan, Guo-Huang
Article Type: Research Article
Abstract: Truncation of tau protein is considered an early event in Alzheimer’s disease (AD) and is believed to play a major pathogenic role in sporadic AD. However, causative factors that trigger tau truncation in AD remain poorly understood. In the present study, we demonstrate that CXCL1 (C-X-C motif ligand 1), a specific ligand for the chemokine receptor CXCR2, induced cleavage of tau at ASP421 in a caspase-3-dependent manner in long-term but not short-term cultured neurons. The cleaved tau formed varicosities or bead-like structures along the neurites, an abnormal distribution of tau induced by CXCL1 that has not been observed previously. …CXCL1-induced activation of GSK3β and the subsequent phosphorylation of tau preceded and were required for caspase-3 activation and tau cleavage. Moreover, intrahippocampal microinjection of lentiviral CXCL1 induced tau cleavage in hippocampal neurons in aged (15–18 months of age) but not adult mice (5–10 months of age). Our data highlight a new role of CXCR2 in tau cleavage and suggest that targeting CXCR2 may offer therapeutic benefits to patients with AD and potentially other tauopathies. Show more
Keywords: Caspase-3, CXCL1, CXCR2, hippocampal neurons, tau cleavage
DOI: 10.3233/JAD-150041
Citation: Journal of Alzheimer's Disease, vol. 48, no. 1, pp. 89-104, 2015
Authors: Kristofikova, Zdena | Ricny, Jan | Vyhnalek, Martin | Hort, Jakub | Laczo, Jan | Sirova, Jana | Klaschka, Jan | Ripova, Daniela
Article Type: Research Article
Abstract: Background: Overexpression of the mitochondrial enzyme 17β-hydroxysteroid dehydrogenase type 10 (17β-HSD10, which is also known as the intracellular amyloid-β peptide (Aβ) binding protein) is observed in cortical or hippocampal regions of patients with Alzheimer’s disease (AD). It appears that 17β-HSD10 may play a role in the pathogenesis of AD. Objective: We investigated the possibility that levels of 17β-HSD10 in cerebrospinal fluid could be a prospective biomarker of AD. Methods: We estimated the enzyme levels in 161 people (15 non-demented controls, 52 people with mild cognitive impairment (MCI), 35 people with probable AD, or …59 people with other types of dementia) and compared them with those of Aβ1 - 42 , tau, and phospho-tau. Results: We found significantly higher levels of 17β-HSD10 in people with MCI due to AD (to 109.9% ), with AD (to 120.0% ), or with other types of dementia (to 110.9% ) when compared to the control group. The sensitivity of the new biomarker to AD was 80.0% , and the specificity was 73.3% (compared to controls) or 52.5–59.1% (compared to other types of dementia). Results of multiple linear regression and of correlation analysis revealed AD-mediated changes in links between 17β-HSD10 and Mini Mental State Examination score. Conclusion: It seems that changes in 17β-HSD10 start many years before symptom onset, analogous to those in Aβ1 - 42 , tau, or phospho-tau and that the levels are a relatively highly sensitive but unfortunately less specific biomarker of AD. A role of 17β-HSD10 overexpression in AD is discussed. Show more
Keywords: 17β-HSD10, Alzheimer’s disease, amyloid-β peptides, biomarker, cerebrospinal fluid
DOI: 10.3233/JAD-142898
Citation: Journal of Alzheimer's Disease, vol. 48, no. 1, pp. 105-114, 2015
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl